Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII‐treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study
Carmen Escuriola Ettingshausen, Roger E. G. Schutgens(University Medical Center Utrecht), Barbara Faganel Kotnik(Ljubljana University Medical Centre), Όλγα Κατσαρού, Sohan Dey(Novo Nordisk (India)), Irina Matytsina(Novo Nordisk (Denmark)), A Derlon(Centre Hospitalier Universitaire de Caen Normandie), Rudolf Schwarz(Universität Hamburg), Paula F. Ypma(Haga Hospital)
Cited by 5
Related Papers
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654
Evaluation of Five Radiation Schedules and Prognostic Factors for Metastatic Spinal Cord Compression
|Journal of Clinical Oncology|2005|347
Osteosarcoma of the Pelvis: Experience of the Cooperative Osteosarcoma Study Group
|Journal of Clinical Oncology|2003|344